| 1996 |
CLNS1A (ICln) was chromosomally mapped to chromosome 11q13.5-q14.1 by FISH, identifying it as an intron-containing gene (~19 kb) encoding a chloride channel essential for regulatory volume decrease. A second intronless pseudogene/locus (CLNS1B) was mapped to 6p12.1-6q13. |
PCR strategies and fluorescence in situ hybridization (FISH) |
Genomics |
Medium |
8975725
|
| 1998 |
The CLNS1A gene at 11q13.5-q14.1 encodes ICln, a chloride channel fundamental for regulatory volume decrease; CLNS1B on chromosome 6p12 is an intronless gene 91.3% homologous to the CLNS1A coding region. |
Gene characterization, sequencing, and chromosomal localization |
Gene |
Medium |
9524223
|
| 2000 |
The CLNS1A gene is driven by a constitutive promoter of 89 nucleotides that lacks a TATA box and initiates transcription at multiple sites; upstream sequence elements are required for efficient transcription. Knockdown of ICln in NIH 3T3 fibroblasts and epithelial cells demonstrated its crucial role in volume regulation after cytoplasmic swelling. Reconstitution of ICln in lipid bilayers confirmed its ion channel nature. |
Promoter deletion analysis, site-directed mutagenesis, ICln knockdown in cell lines, reconstitution in lipid bilayers |
The Journal of biological chemistry |
High |
10821842
|
| 2005 |
CLNS1A (ICln) protein was detected in human spermatozoa by Western blotting in only 1 of 8 samples, and CLNS1A transcripts were found in some but not all sperm samples, indicating variable expression; CLCN3 was identified as the more consistent candidate Cl- channel for sperm volume regulation. |
Western blotting, RT-PCR, flow cytometry-based cell volume measurement with Cl- channel blockers |
Biology of reproduction |
Low |
16033995
|
| 2021 |
CLNS1A is one of three substrate adaptor proteins for PRMT5 (along with RIOK1 and COPR5), all sharing an evolutionarily conserved peptide sequence (binding motif) that is necessary and sufficient for interaction with PRMT5. Structural resolution of the CLNS1A-PRMT5 interface showed that PRMT5 uses modular adaptor proteins with a common binding motif for substrate recruitment. Genetic disruption of this interface impairs Sm spliceosome methylation, causing intron retention, and impairs growth of MTAP-null tumor cells. |
Biochemical identification of conserved peptide motif, structural resolution of PRMT5-adaptor interface, genetic perturbation (mutagenesis), spliceosome activity assays, cell growth assays |
Molecular cell |
High |
34358446
|
| 2024 |
Knockdown of CLNS1A (pICln), the PRMT5 adaptor that specifically enables Sm protein methylation, caused detention of mRNA (GRIPPs—genomically retained incompletely processed polyadenylated transcripts), accumulation of SNRPB and SNRPD3 on chromatin, and upregulation of detained introns. This demonstrated that CLNS1A-mediated PRMT5 activity on Sm proteins is required for mRNA chromatin escape and nuclear export. |
CLNS1A knockdown combined with fractionated transcriptomics (nascent and total RNA-seq), fractionated proteomics, isogenic SNRPB arginine mutants |
bioRxiv : the preprint server for biologypreprint |
Medium |
39149374
|
| 2025 |
CLNS1A knockdown (pICln depletion) caused detention of polyadenylated mRNA and Sm proteins on chromatin, confirming that CLNS1A-mediated PRMT5 Sm-protein methylation is essential for mRNA processing and chromatin escape. Biochemical assays showed the SMN Tudor domain competes with nucleic acid binding of methylated Sm tails, providing a mechanistic link between arginine methylation and RNA-chromatin dynamics. |
CLNS1A knockdown, spike-in normalized fractionated transcriptomics, fractionated proteomics, isogenic SNRPB arginine mutants, biochemical competition assays (SMN Tudor domain vs. nucleic acids) |
Molecular cell |
High |
41086806
|
| 2025 |
CLNS1A depletion was sufficient to induce detained intron (DI) upregulation, cell cycle defects, and loss of viability in a manner dependent on loss of Sm protein methylation. This established that CLNS1A specifically enables PRMT5-mediated Sm protein methylation, and that this function underlies the PRMT5-splicing axis central to cancer vulnerability. |
CLNS1A depletion, detained intron splicing assays, cell viability assays, cell cycle analysis |
iScience |
Medium |
40687829
|
| 2025 |
In CD4 T cells, CLNS1A interacts with PRMT5 and regulates symmetric histone dimethylation (H4R3me2s) and expression of genes involved in DNA repair, replication, and cell cycle progression. Deletion of Clns1a in T cells caused DNA damage, cell cycle arrest, and impaired T cell proliferation and effector function, protecting mice from EAE and IBD. |
Forward genetic screen, T cell-specific Clns1a knockout mice, Co-immunoprecipitation (CLNS1A-PRMT5 interaction), histone methylation assays, EAE and IBD mouse models |
Science immunology |
High |
40540585
|
| 2025 |
CLNS1A promotes drug efflux through its chloride channel activity and activates the FAK-SRC-RAC1 pathway to enhance cell motility and clonogenicity in lung cancer cells. It also facilitates PRMT5-mediated RUVBL1 methylation to support anti-apoptotic DNA damage response signaling. A chloride channel-defective 3W mutant (with steric hindrance at key bottleneck residues) impaired chloride ion transport, reducing drug resistance and migration. |
CLNS1A overexpression and knockdown in lung cancer cell lines, site-directed mutagenesis (3W mutant), drug accumulation assays, IC50 measurements, pathway inhibition, in vivo xenograft models |
Cancer letters |
Medium |
40345428
|
| 2025 |
AlphaFold 3 modeling of the human 6S intermediate complex (full-length pICln/CLNS1A with SmD1/D2/E/F/G) combined with integration of prior biochemical data supports a model in which ULK1-dependent serine phosphorylation in the C-terminal alpha-helix of pICln abrogates its secondary structure, weakens interaction with SmG, and facilitates displacement of pICln by the SmD3/B dimer during spliceosomal Sm core assembly. |
AlphaFold 3 computational structural modeling integrated with published biochemical data |
Computational and structural biotechnology journal |
Low |
41503269
|